46.4
Lipocine Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
34.1
FY23:
22.9
FY24:
22.3
FY25:
16.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.10
FY22:
3.41
FY23:
0.14
FY24:
0.19
FY25:
0.13
Total assets
Change from FY21 to FY25
millions USD
FY21:
52.5
FY22:
37.5
FY23:
23.0
FY24:
22.5
FY25:
17.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.62
FY22:
1.68
FY23:
2.63
FY24:
1.51
FY25:
2.53
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.30
FY22:
0.23
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
45.6
FY22:
35.6
FY23:
20.4
FY24:
21.0
FY25:
14.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
52.5
FY22:
37.5
FY23:
23.0
FY24:
22.5
FY25:
17.0
All amounts in millions USD